Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, side effects, cost, and why it matters now.
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle strength, mobility, and survival.
Breaking down the new 2025-2030 U.S. Dietary Guidelines: why the alcohol limit is now one drink or less per day and the key research that prompted this shift.
TEAM may encourage hospitals to improve the quality of the care their patients receive after being discharged. But it also risks further burdening family caregivers. I
If a political debate takes place this year on the topic of ACA cost containment and the affordability of premiums, it’s hoped that reform initiatives won’t be piecemeal.
Former Flatiron Health exec Marta Bralic Kerns raised $92 million to expand her virtual care model to women at all stages of their lives.
Sweeping changes prioritize protein and fats over processed carbs, challenging decades of dietary dogma and setting the stage for a major public health debate.
A coalition of telehealth providers from Amazon and Hims & Hers to hospital systems is working to extend pandemic-era waivers that allowed Medicare telehealth coverage.
In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, Wegovy’s weight-loss pill, and more.
Expert physician, Dr. Aly Cohen, explains ways to limit our exposure to toxins in our daily life.